Growth Metrics

Alnylam Pharmaceuticals (ALNY) Operating Margin Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -40,178.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 530.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1,211.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 6,993.00
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6,993.00
Dec 31, 2025 6,830.00
Sep 30, 2025 12,709.00
Jun 30, 2025 8,317.00
Mar 31, 2025 12,906.00
Dec 31, 2024 5,753.00
Sep 30, 2024 8,147.00
Jun 30, 2024 7,364.00
Mar 31, 2024 9,611.00
Dec 31, 2023 9,227.00
Sep 30, 2023 20,743.00
Jun 30, 2023 11,918.00
Mar 31, 2023 16,435.00
Dec 31, 2022 35,954.00
Sep 30, 2022 21,110.00
Jun 30, 2022 44,314.00
Mar 31, 2022 49,823.00
Dec 31, 2021 97,241.00
Sep 30, 2021 1.22 Mn
Jun 30, 2021 57,690.00
Mar 31, 2021 56,822.00
Dec 31, 2020 26,967.00
Sep 30, 2020 55,691.00
Jun 30, 2020 56,490.00
Mar 31, 2020 35,050.00
Dec 31, 2019 24,552.00
Sep 30, 2019 47,272.00
Jun 30, 2019 53,314.00
Mar 31, 2019 93,097.00
Dec 31, 2018 17,749.00
Sep 30, 2018 -1.11 Mn
Jun 30, 2018 19,671.00
Mar 31, 2018 -39,140.00
Dec 31, 2017 -19,810.00
Sep 30, 2017 -32,390.00
Jun 30, 2017 -13,925.00
Mar 31, 2017 268,976.00
Dec 31, 2016 -38,854.00
Sep 30, 2016 -42,294.00
Jun 30, 2016 -81,621.00
Mar 31, 2016 -144,541.00
Dec 31, 2015 -18,515.00
Sep 30, 2015 -113,033.00
Jun 30, 2015 -78,210.00
Mar 31, 2015 -22,881.00
Dec 31, 2014 -12,390.00
Sep 30, 2014 -35,212.00
Jun 30, 2014 -55,329.00
Mar 31, 2014 -317,651.00
Dec 31, 2013 -21,425.00
Sep 30, 2013 -32,697.00
Jun 30, 2013 -20,165.00
Mar 31, 2013 -656.00
Dec 31, 2012 -100,971.00
Sep 30, 2012 -6,849.00
Jun 30, 2012 3,332.00